COVID-19 has led to the suspension of polio campaigns in more than 30 countries, and has underscored the importance of the mission to eradicate it, tackle antimicrobial resistance, and ensure the timely sharing of pathogens, said WHO member states at Monday’s Executive Board session.  Throughout the morning and afternoon sessions, member states reviewed and discussed […] Continue reading ->
WHO called on European countries to step up their game to curb the highly contagious COVID-19 variants that are overtaking the region, already straining overstretched health systems. Meanwhile some researchers were warning that the new virus variants could spell double trouble if the mutation first identified in South Africa, in particular, makes new vaccines just […] Continue reading ->
This week is World Antimicrobial Awareness Week, marking the fight against the silent and rising global threat of antimicrobial-resistant superbugs. Can patients be part of the solution? This week is the World Antimicrobial Awareness Week (WAAW) when we turn the world’s attention to the growing problem of drug resistant diseases – caused by bacteria, viruses […] Continue reading ->
Second in a series – On Wednesday, 18 November, at 2pm CET, leading experts at the Geneva Health Forum (GHF) 2020 will provide their take on how to move forward on the recently approved WHO global strategy to accelerate the elimination of cervical cancer, which kills 300,000 women every year, mostly in low-resource settings like […] Continue reading ->
A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available.  Appearing at the Paris Peace Forum, Melinda […] Continue reading ->
The COVID-19 pandemic will end at some point. But TB, tobacco use, air pollution and other lung diseases will continue to “steal the breath and life of millions of people every year”, unless we reimagine the future, said WHO’s director-general Dr Tedros Adhanon Ghebreyesus, appearing at the opening of the 51st Union World Conference On […] Continue reading ->
As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls.  Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading ->